Lv41
458 积分 2024-11-12 加入
Heart Rate and Cardiovascular Outcomes in Post–Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial
58分钟前
求助中
Dapagliflozin in Patients With Heart Failure Across the Care Spectrum: A Meta-Analysis of DAPA-HF, DELIVER, and DAPA ACT HF-TIMI 68
6小时前
求助中
Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction An Updated Systematic Review and Network Meta-Analysis
4天前
已完结
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
4天前
已完结
Pharmacologic Treatment of Heart Failure With Reduced Ejection Fraction
4天前
已完结
Vericiguat: VICTORy or Defeat?
4天前
已关闭
Vericiguat in heart failure with reduced ejection fraction: being confident in the face of uncertainty
11天前
已完结
Beyond the 4 Pillars
11天前
已完结
The Role of Vericiguat for Treatment of Heart Failure With Reduced Ejection Fraction
11天前
已完结
The Effect of Vericiguat on Recurrent Heart Failure Hospitalization and Death in Ambulatory HFrEF
11天前
已完结
皖公网安备34019202002308
